|Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA|
M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ...
|Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension|
EAB Azizan, H Poulsen, P Tuluc, J Zhou, MV Clausen, A Lieb, C Maniero, ...
Nature genetics 45 (9), 1055, 2013
|Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer|
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6, 8760, 2015
|Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer|
MKH Hong, G Macintyre, DC Wedge, P Van Loo, K Patel, S Lunke, ...
Nature communications 6, 6605, 2015
|Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma|
L Gossage, M Murtaza, AF Slatter, CP Lichtenstein, A Warren, B Haynes, ...
Genes, chromosomes and cancer 53 (1), 38-51, 2014
|Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma|
M Köbel, AM Piskorz, S Lee, S Lui, C LePage, F Marass, N Rosenfeld, ...
The Journal of Pathology: Clinical Research 2 (4), 247-258, 2016
|Enhanced detection of circulating tumor DNA by fragment size analysis|
F Mouliere, D Chandrananda, AM Piskorz, EK Moore, J Morris, ...
Science translational medicine 10 (466), eaat4921, 2018
|A 44K microarray dataset of the changing transcriptome in developing Atlantic salmon (Salmo salar L.)|
SG Jantzen, DS Sanderson, KR von Schalburg, M Yasuike, F Marass, ...
BMC research notes 4 (1), 88, 2011
|Association of plasma and urinary mutant DNA with clinical outcomes in muscle invasive bladder cancer|
KM Patel, KE Van Der Vos, CG Smith, F Mouliere, D Tsui, J Morris, ...
Scientific reports 7 (1), 1-12, 2017
|A phylogenetic latent feature model for clonal deconvolution|
F Marass, F Mouliere, K Yuan, N Rosenfeld, F Markowetz
The Annals of Applied Statistics 10 (4), 2377-2404, 2016
|Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients|
F Mouliere, R Mair, D Chandrananda, F Marass, CG Smith, J Su, J Morris, ...
EMBO molecular medicine 10 (12), 2018
|Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients|
B Risberg, DWY Tsui, H Biggs, ARVM de Almagro, SJ Dawson, ...
The Journal of Molecular Diagnostics 20 (6), 883-892, 2018
|Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer|
DWY Tsui, M Murtaza, ASC Wong, OM Rueda, CG Smith, ...
EMBO molecular medicine 10 (6), e7945, 2018
|Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models.|
R Mair, F Mouliere, CG Smith, D Chandrananda, D Gale, F Marass, ...
Cancer Research, canres. 0074.2018, 2018
|Sequence Searcher: A Java tool to perform regular expression and fuzzy searches of multiple DNA and protein sequences|
F Marass, C Upton
BMC research notes 2 (1), 14, 2009
|CVE: an R package for interactive variant prioritisation in precision oncology|
A Mock, S Murphy, J Morris, F Marass, N Rosenfeld, C Massie
BMC medical genomics 10 (1), 37, 2017
|Bayesian non-parametric clustering of single-cell mutation profiles|
N Borgsmueller, J Bonet, F Marass, A Gonzalez-Perez, N Lopez-Bigas, ...
|High-sensitivity monitoring of ctDNA by patient-specific sequencing panels and integration of variant reads|
JCM Wan, K Heider, D Gale, S Murphy, E Fisher, J Morris, F Mouliere, ...
bioRxiv, 759399, 2019
|Latent feature models and non-invasive clonal reconstruction|
University of Cambridge, 2017
|Individualised monitoring of patients with metastatic melanoma using plasma DNA|
J Wan, S Murphy, D Gale, J Morris, FC Mouliere, F Marass, K Heider, ...
The Lancet 389, S99, 2017